Kariv Tomer
- SEC CIK
- 0001568077
Latest role at each company
- KROS Keros Therapeutics, Inc.Director, 10% Owneras of Oct 17, 2025
- ELOX Eloxx Pharmaceuticals, Inc.Directoras of Jan 31, 2023
Trades
Every Form 4 that lists Kariv Tomer as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| KROSKeros Therapeutics, Inc. | Oct 17, 20255:53 PM ET | Oct 15, 2025 | Kariv Tomer and 7 othersDirector, 10% Owner | SSaleCommon Stock, $0.0001 par value per share | −4.79M | $17.75 | −$84.98M | 0 | −100.0% | SEC |